Meishu Xu

机构：University of Pittsburgh

发表论文 70 篇 · 总被引 1896 次 · h-index 26

代表论文

• The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1 (2021 · Science Advances · 被引 65)
• Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure (2021 · Gastroenterology · 被引 38)
• Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose (2024 · Science Translational Medicine · 被引 18)
• Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma (2022 · Hepatology Communications · 被引 18)
• Inhibition of the SLC35B2–TPST2 Axis of Tyrosine Sulfation Attenuates the Growth and Metastasis of Pancreatic Ductal Adenocarcinom (2023 · Cellular and Molecular Gastroenterology and Hepatology · 被引 15)
• Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis (2023 · Acta Pharmaceutica Sinica B · 被引 13)